VCG
Vantage Consulting Group’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-57,500
| Closed | -$1.56M | – | 216 |
|
|
2023
Q3 | $1.56M | Sell |
57,500
-593,190
| -91% | -$16.1M | 1.05% | 6 |
|
|
2023
Q2 | $20M | Sell |
650,690
-371,504
| -36% | -$11.4M | 11.51% | 2 |
|
|
2023
Q1 | $36.8M | Hold |
1,022,194
| – | – | 20.91% | 2 |
|
|
2022
Q4 | $35.5M | Hold |
1,022,194
| – | – | 20.94% | 2 |
|
|
2022
Q3 | $41.1M | Sell |
1,022,194
-29,701
| -3% | -$1.19M | 24% | 2 |
|
|
2022
Q2 | $44.2M | Sell |
1,051,895
-1,675,959
| -61% | -$70.5M | 24.8% | 2 |
|
|
2022
Q1 | $106M | Sell |
2,727,854
-1,873,298
| -41% | -$73M | 41.47% | 1 |
|
|
2021
Q4 | $183M | Sell |
4,601,152
-3,261,390
| -41% | -$130M | 49.3% | 1 |
|
|
2021
Q3 | $284M | Sell |
7,862,542
-1,439,903
| -15% | -$52M | 60.85% | 1 |
|
|
2021
Q2 | $381M | Buy |
9,302,445
+596,894
| +7% | +$24.5M | 66.33% | 1 |
|
|
2021
Q1 | $380M | Sell |
8,705,551
-12,771,731
| -59% | -$557M | 76.23% | 1 |
|
|
2020
Q4 | $1.07B | Buy |
+21,477,282
| New | +$1.07B | 87.53% | 1 |
|